Cargando…
The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation
Polo-like kinase-1 (PLK1) plays a major role in driving mitotic events, including centrosome disjunction and separation, and is frequently over-expressed in human cancers. PLK1 inhibition is a promising therapeutic strategy and works by arresting cells in mitosis due to monopolar spindles. The p53 t...
Autores principales: | Smith, Linda, Farzan, Raed, Ali, Simak, Buluwela, Laki, Saurin, Adrian T., Meek, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701047/ https://www.ncbi.nlm.nih.gov/pubmed/29170437 http://dx.doi.org/10.1038/s41598-017-16394-2 |
Ejemplares similares
-
Author Correction: The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation
por: Smith, Linda, et al.
Publicado: (2018) -
Differential control of Eg5-dependent centrosome separation by Plk1 and Cdk1
por: Smith, Ewan, et al.
Publicado: (2011) -
p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells
por: Periyasamy, Manikandan, et al.
Publicado: (2017) -
Mitotic Acetylation of Microtubules Promotes Centrosomal PLK1 Recruitment and Is Required to Maintain Bipolar Spindle Homeostasis
por: Rasamizafy, Sylvia Fenosoa, et al.
Publicado: (2021) -
Gravin regulates centrosome function through PLK1
por: Colicino, Erica G., et al.
Publicado: (2018)